ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
8.98
-0.41 (-4.37%)
At close: Oct 29, 2025, 4:00 PM EDT
9.05
+0.07 (0.78%)
After-hours: Oct 29, 2025, 7:57 PM EDT

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022
Period Ending
Dec '23 Dec '22
Needle-free Intranasal
30.00K
Log In
Needle-free Intranasal Growth
-97.72%
Log In

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022
Period Ending
Dec '23 Dec '22
United States
30.00K
Log In
United States Growth
-97.72%
Log In